Opportunity Information: Apply for RFA NS 22 069
The HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional) funding opportunity (RFA-NS-22-069) is a National Institutes of Health (NIH) grant solicitation aimed at supporting ambitious, tightly coordinated team science in pain research. Its central purpose is to accelerate major advances in understanding the biology of human pain by integrating basic and clinical approaches in a way that a single laboratory or traditional single-PI project typically cannot. The FOA is positioned within the broader HEAL (Helping to End Addiction Long-term) Initiative context, emphasizing research that can meaningfully improve how pain is understood, stratified, and ultimately managed.
A defining feature of this opportunity is its required multi-PI structure: applications must be led by a team of three or more Program Directors/Principal Investigators (PDs/PIs), up to a maximum of six. The expectation is not simply that multiple leaders contribute separate pieces, but that the team functions as an integrated unit with real collaboration, deliberate coordination, and clear scientific synergy. NIH is explicitly signaling that it does not want a bundle of loosely connected projects or parallel workstreams. Instead, the application must present one cohesive, well-integrated research plan with a single overarching focus, one unified set of specific aims, and a consolidated budget that does not break into subprojects. In practical terms, the proposed science should be constructed so that the major questions can only be answered through coordinated team interactions, shared frameworks, and cross-disciplinary methods, rather than through independent efforts that happen to share a topic area.
Scientifically, the FOA supports research across both basic and clinical pain domains, with an emphasis on understanding the biology of specific human pain conditions as well as pain associated with a wide range of diseases and disorders. A major priority is tackling heterogeneity in pain: why patients with the same diagnosis can experience pain differently, respond differently to treatments, or follow different trajectories over time. The announcement highlights the importance of mechanistic underpinnings of that heterogeneity and encourages approaches that enable patient stratification, including consideration of co-morbidities that frequently complicate pain conditions. The overarching idea is to move beyond one-size-fits-all models of pain and toward biologically informed categories, mechanisms, and markers that can guide more precise clinical strategies.
Methodologically, the FOA calls for interdisciplinary research teams that can develop and apply new principles and methods for experimentation, analysis, and interpretation. That often implies combining complementary strengths such as clinical phenotyping, computational or statistical modeling, mechanistic biology, neurobiology, imaging, omics, biomarker discovery, behavioral science, and other relevant disciplines depending on the pain condition and scientific premise. The emphasis on developing new approaches is a signal that incremental or conventional designs may be less competitive than work that proposes genuinely enabling tools, platforms, datasets, analytic frameworks, or integrative experimental strategies that push the field forward.
The program also stresses a forward-looking, outcome-oriented mindset. Teams are encouraged to propose transformative objectives with clearly defined five-year outcomes, meaning the work should be planned around concrete deliverables and advances that are plausible within the project period. The intended impact is not just academic knowledge, but advances that are likely to improve strategies for effective management of human pain, whether through better mechanistic understanding, improved patient stratification, identification of actionable targets, or development of evidence that can inform clinical decision-making. The FOA is labeled “Clinical Trial Optional,” indicating that a clinical trial may be included if scientifically appropriate, but it is not required for all applications.
Eligibility is broad and spans many organization types, reflecting NIH’s interest in attracting diverse teams and institutional settings. Eligible applicants include various levels of government (state, county, city/township, and special districts), independent school districts, public and private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), certain tribal governments and tribal organizations, faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations) as well as regional organizations. This breadth supports the formation of multi-institutional, multidisciplinary collaborations and encourages participation from a wide range of research communities.
Key administrative details from the source include the sponsoring agency (National Institutes of Health), the funding instrument (grant), the opportunity category (discretionary), and the closing date listed as February 13, 2024. The opportunity is associated with multiple CFDA numbers, reflecting the multi-institute and multi-program nature of NIH’s HEAL-related pain research funding. The award ceiling and expected number of awards are not specified in the provided listing, which typically means applicants should consult the full FOA text and NIH guidance for budget expectations, project period norms, and any institute-specific considerations.
Overall, this FOA is best understood as a team-science mechanism intended for research groups that can truly integrate basic and clinical pain research into one unified plan, aimed at explaining and predicting real-world variability in human pain and translating that understanding into better paths for pain management. The competitive applications will be those that demonstrate genuine interdependence among PDs/PIs, a clear and singular scientific vision, and a credible plan to deliver major advances within a defined five-year window.Apply for RFA NS 22 069
- The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.233, 93.273, 93.393, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866.
- This funding opportunity was created on 2022-11-04.
- Applicants must submit their applications by 2024-02-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional) - RFA-NS-22-069
What is this funding opportunity?
This is a National Institutes of Health (NIH) grant solicitation under the HEAL (Helping to End Addiction Long-term) Initiative titled "Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)" (RFA-NS-22-069). It supports ambitious, tightly coordinated team science intended to accelerate major advances in understanding the biology of human pain through integrated basic and clinical research.
What is the main purpose of the FOA?
The central purpose is to speed up meaningful progress in understanding the biology of human pain by combining basic and clinical approaches in ways that a single laboratory or a traditional single-PI project typically cannot. The FOA emphasizes advances that can improve how pain is understood, stratified, and ultimately managed.
How does this FOA define "team science"?
The FOA expects real collaboration and scientific interdependence across an integrated multi-PI team. NIH is not looking for loosely connected projects or parallel workstreams. Instead, the work should be deliberately coordinated so that the major scientific questions can only be answered through shared frameworks, cross-disciplinary methods, and coordinated team interactions.
How many PDs/PIs are required, and what is the maximum?
Applications must be led by a team of at least three Program Directors/Principal Investigators (PDs/PIs). The team can include up to a maximum of six PDs/PIs.
Can a single-PI application be submitted?
No. A defining feature of this opportunity is the required multi-PI structure (3-6 PDs/PIs).
Does the application need one unified research plan or separate projects?
The application must present one cohesive, well-integrated research plan with a single overarching focus and one unified set of specific aims. It should not be structured as a bundle of separate subprojects.
How should the budget be organized?
The FOA calls for a consolidated budget that does not break into subprojects. The expectation is that the team is proposing one integrated program rather than multiple semi-independent components.
What types of pain research are supported?
The FOA supports both basic and clinical pain research, with an emphasis on understanding the biology of specific human pain conditions and pain associated with a wide range of diseases and disorders.
What scientific theme is emphasized in the FOA?
A major priority is addressing heterogeneity in pain, such as why patients with the same diagnosis can experience pain differently, respond differently to treatments, or have different trajectories over time. The FOA encourages research on mechanistic drivers of this variability and approaches that enable patient stratification.
Does the FOA encourage consideration of co-morbidities?
Yes. The FOA encourages considering co-morbidities that frequently complicate pain conditions, particularly when they affect pain heterogeneity, patient stratification, or clinical trajectories.
What does "patient stratification" mean in the context of this FOA?
Within this FOA, patient stratification refers to approaches that move beyond one-size-fits-all models of pain by identifying biologically informed categories, mechanisms, or markers that help explain differences between patients and can guide more precise clinical strategies.
What kinds of methods and disciplines are encouraged?
The FOA calls for interdisciplinary teams that can develop and apply new principles and methods for experimentation, analysis, and interpretation. Examples of complementary strengths mentioned include clinical phenotyping, computational or statistical modeling, mechanistic biology, neurobiology, imaging, omics, biomarker discovery, and behavioral science, among other relevant disciplines.
Is the FOA more interested in incremental research or transformative approaches?
The FOA signals interest in work that is enabling and forward-moving, including new tools, platforms, datasets, analytic frameworks, or integrative experimental strategies. Conventional or incremental approaches may be less aligned than proposals that clearly push the field forward.
What is meant by "five-year outcomes"?
The program emphasizes a forward-looking, outcome-oriented plan with clearly defined outcomes that are feasible within a five-year project period. The idea is to plan around concrete deliverables and advances rather than only broad exploratory aims.
What kinds of impacts does NIH want from funded projects?
The intended impact goes beyond academic knowledge. The FOA aims for advances likely to improve strategies for effective management of human pain, such as better mechanistic understanding, improved patient stratification, identification of actionable targets, or evidence that can inform clinical decision-making.
Are clinical trials required?
No. The FOA is labeled "Clinical Trial Optional," meaning a clinical trial may be included if scientifically appropriate, but it is not required for all applications.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
What is the funding instrument and opportunity category?
The funding instrument is a grant, and the opportunity category is discretionary.
What is the closing date listed for this opportunity?
The closing date listed in the provided information is February 13, 2024.
Are award amounts (award ceiling) and the expected number of awards provided?
No. The award ceiling and expected number of awards are not specified in the provided listing. The summary indicates that applicants would typically consult the full FOA text and NIH guidance for budget expectations and other details.
Are CFDA numbers associated with this opportunity?
Yes. The opportunity is associated with multiple CFDA numbers, reflecting the multi-institute and multi-program nature of NIH HEAL-related pain research funding.
What types of organizations are eligible to apply?
Eligibility is broad and includes many organization types: state, county, and city/township governments; special districts; independent school districts; public and private institutions of higher education; nonprofit organizations (501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); and small businesses.
Are minority-serving institutions and tribal entities eligible?
Yes. The FOA explicitly highlights additional eligible applicant categories including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); certain tribal governments and tribal organizations; and other listed categories.
Are faith-based and community-based organizations eligible?
Yes. The eligibility list explicitly includes faith-based or community-based organizations.
Can non-U.S. organizations apply?
Yes. The FOA indicates that non-U.S. entities (foreign organizations) are eligible, and it also lists regional organizations among eligible applicants.
Are U.S. territories or possessions included in eligibility?
Yes. U.S. territories or possessions are included among the eligible applicant types.
Is NIH encouraging multi-institutional collaborations?
The breadth of eligible organizations supports multi-institutional and multidisciplinary collaborations. The FOA is framed as a team-science mechanism where integrating expertise and approaches across settings is part of the intent.
What makes an application a strong fit for this FOA based on the summary?
Competitive applications are described as those that demonstrate genuine interdependence among PDs/PIs, a clear and singular scientific vision, a truly integrated basic-and-clinical approach, and a credible plan to deliver major advances and defined outcomes within a five-year window.
What is an example of what NIH does not want to see?
The summary indicates NIH does not want a set of loosely connected projects, parallel workstreams, or an application that reads like multiple independent efforts sharing a topic. The FOA expects one cohesive plan with unified aims and an integrated structure.
Browse more opportunities from the same category: Education, Health, Income Security and Social Services
Next opportunity: Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
Previous opportunity: Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 22 069
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 22 069) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 066 Funding Number: PAR 23 066 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $500,000 |
| HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required) Apply for RFA NS 22 023 Funding Number: RFA NS 22 023 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA NS 22 022 Funding Number: RFA NS 22 022 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA NS 22 025 Funding Number: RFA NS 22 025 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required) Apply for RFA NS 22 024 Funding Number: RFA NS 22 024 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) Apply for RFA MH 23 335 Funding Number: RFA MH 23 335 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Apply for PAR 23 075 Funding Number: PAR 23 075 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA EB 22 003 Funding Number: RFA EB 22 003 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $300,000 |
| HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) Apply for RFA NS 24 018 Funding Number: RFA NS 24 018 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) Apply for PAR 23 131 Funding Number: PAR 23 131 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $225,000 |
| Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) Apply for RFA OD 23 014 Funding Number: RFA OD 23 014 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $350,000 |
| Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) Apply for RFA OD 23 013 Funding Number: RFA OD 23 013 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $275,000 |
| Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed) Apply for PAR 23 123 Funding Number: PAR 23 123 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: $550,000 |
| BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) Apply for RFA NS 24 005 Funding Number: RFA NS 24 005 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) Apply for RFA NS 24 004 Funding Number: RFA NS 24 004 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional) Apply for RFA MH 23 130 Funding Number: RFA MH 23 130 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for RFA MH 23 110 Funding Number: RFA MH 23 110 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) Apply for RFA DC 24 001 Funding Number: RFA DC 24 001 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) Apply for RFA MH 23 270 Funding Number: RFA MH 23 270 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
| BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA MH 23 331 Funding Number: RFA MH 23 331 Agency: National Institutes of Health Category: Education, Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 22 069", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.